Literature DB >> 30481307

Polymorphisms in TLR4 and TNFA and Risk of Mycobacterium tuberculosis Infection and Development of Active Disease in Contacts of Tuberculosis Cases in Brazil: A Prospective Cohort Study.

Juan Manuel Cubillos-Angulo1,2,3, María B Arriaga1,2,3, Elisângela C Silva4,5, Beatriz L A Müller4,6, Daniela M P Ramalho4, Kiyoshi F Fukutani1,3, Pryscila F C Miranda4, Adriana S R Moreira4, Antonio Ruffino-Netto7, Jose R Lapa E Silva4, Timothy R Sterling8, Afrânio L Kritski4, Martha M Oliveira9, Bruno B Andrade1,3,8,10,11,12.   

Abstract

BACKGROUND: The role of genetic polymorphisms in latent tuberculosis (TB) infection and progression to active TB is not fully understood.
METHODS: We tested the single-nucleotide polymorphisms (SNPs) rs5743708 (TLR2), rs4986791 (TLR4), rs361525 (TNFA), rs2430561 (IFNG) rs1143627 (IL1B) as risk factors for tuberculin skin test (TST) conversion or development of active TB in contacts of active TB cases. Contacts of microbiologically confirmed pulmonary TB cases were initially screened for longitudinal evaluation up to 24 months, with clinical examination and serial TST, between 1998 and 2004 at a referral center in Brazil. Data and biospecimens were collected from 526 individuals who were contacts of 177 active TB index cases. TST conversion was defined as induration ≥5 mm after a negative TST result (0 mm) at baseline or month 4 visit. Independent associations were tested using logistic regression models.
RESULTS: Among the 526 contacts, 60 had TST conversion and 44 developed active TB during follow-up. Multivariable regression analysis demonstrated that male sex (odds ratio [OR]: 2.3, 95% confidence interval [CI]: 1.1-4.6), as well as SNPs in TLR4 genes (OR: 62.8, 95% CI: 7.5-525.3) and TNFA (OR: 4.2, 95% CI: 1.9-9.5) were independently associated with TST conversion. Moreover, a positive TST at baseline (OR: 4.7, 95% CI: 2.3-9.7) and SNPs in TLR4 (OR: 6.5, 95% CI: 1.1-36.7) and TNFA (OR: 12.4, 95% CI:5.1-30.1) were independently associated with incident TB.
CONCLUSIONS: SNPs in TLR4 and TNFA predicted both TST conversion and active TB among contacts of TB cases in Brazil.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Mycobacterium tuberculosiszzm321990 ; Toll-like receptor; single-nucleotide polymorphism; tuberculin skin test; tumor necrosis factor

Year:  2019        PMID: 30481307      PMCID: PMC6735688          DOI: 10.1093/cid/ciy1001

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  34 in total

1.  Sex, gender, and tuberculosis.

Authors:  V K Diwan; A Thorson
Journal:  Lancet       Date:  1999-03-20       Impact factor: 79.321

Review 2.  Exogenous reinfection in tuberculosis.

Authors:  Chen-Yuan Chiang; Lee W Riley
Journal:  Lancet Infect Dis       Date:  2005-10       Impact factor: 25.071

3.  Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin.

Authors:  A G Bean; D R Roach; H Briscoe; M P France; H Korner; J D Sedgwick; W J Britton
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

4.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

Authors:  J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

Review 5.  Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management.

Authors:  Michael A Gardam; Edward C Keystone; Richard Menzies; Steven Manners; Emil Skamene; Richard Long; Donald C Vinh
Journal:  Lancet Infect Dis       Date:  2003-03       Impact factor: 25.071

Review 6.  Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis.

Authors:  Janina Morrison; Madhukar Pai; Philip C Hopewell
Journal:  Lancet Infect Dis       Date:  2008-04-29       Impact factor: 25.071

7.  Risk factors for tuberculosis infection in sub-Saharan Africa: a contact study in The Gambia.

Authors:  Christian Lienhardt; Katherine Fielding; Jackson Sillah; Abdulaye Tunkara; Simon Donkor; Kebba Manneh; David Warndorff; Keith P McAdam; Steve Bennett
Journal:  Am J Respir Crit Care Med       Date:  2003-05-28       Impact factor: 21.405

8.  Toll-like receptors TLR1, TLR2 and TLR4 gene mutations and natural resistance to Mycobacterium avium subsp. paratuberculosis infection in cattle.

Authors:  R Mucha; M R Bhide; E B Chakurkar; M Novak; I Mikula
Journal:  Vet Immunol Immunopathol       Date:  2008-12-06       Impact factor: 2.046

9.  IFNG +874T/A, IL10 -1082G/A and TNF -308G/A polymorphisms in association with tuberculosis susceptibility: a meta-analysis study.

Authors:  Antonio Guilherme Pacheco; Cynthia Chester Cardoso; Milton Ozório Moraes
Journal:  Hum Genet       Date:  2008-04-15       Impact factor: 4.132

10.  TNF influences chemokine expression of macrophages in vitro and that of CD11b+ cells in vivo during Mycobacterium tuberculosis infection.

Authors:  Holly M Scott Algood; Philana Ling Lin; David Yankura; Alvin Jones; John Chan; JoAnne L Flynn
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

View more
  8 in total

1.  Toll-like receptor 4 signaling-mediated responses are critically engaged in optimal host protection against highly virulent Mycobacterium tuberculosis K infection.

Authors:  Jaehun Park; Hongmin Kim; Kee Woong Kwon; Hong-Hee Choi; Soon Myung Kang; Jung Joo Hong; Sung Jae Shin
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

2.  Polymorphisms in interferon pathway genes and risk of Mycobacterium tuberculosis infection in contacts of tuberculosis cases in Brazil.

Authors:  Juan Manuel Cubillos-Angulo; María B Arriaga; Mayla G M Melo; Elisangela C Silva; Lucia Elena Alvarado-Arnez; Alexandre S de Almeida; Milton O Moraes; Adriana S R Moreira; Jose R Lapa E Silva; Kiyoshi F Fukutani; Timothy R Sterling; Thomas R Hawn; Afrânio L Kritski; Martha M Oliveira; Bruno B Andrade
Journal:  Int J Infect Dis       Date:  2019-12-13       Impact factor: 3.623

3.  Deciphering a TB-related DNA methylation biomarker and constructing a TB diagnostic classifier.

Authors:  Mengyuan Lyu; Jian Zhou; Lin Jiao; Yili Wang; Yanbing Zhou; Hongli Lai; Wei Xu; Binwu Ying
Journal:  Mol Ther Nucleic Acids       Date:  2021-11-19       Impact factor: 8.886

4.  MIR337-3p Enhances Mycobacterial Pathogenicity Involving TLR4/MYD88 and STAT3 Signals, Impairing VDR Antimicrobial Response and Fast-Acting Immunity.

Authors:  Shanshan Liang; Guixian Huang; Tian Wu; Ying Peng; Xi Liu; Xuejiao Ji; Wei Sha; Feifei Wang; Ling Shen; Hongbo Shen
Journal:  Front Immunol       Date:  2021-11-29       Impact factor: 7.561

5.  Association of Single Nucleotide Polymorphism rs17580 with Smoking and Pulmonary Tuberculosis.

Authors:  Tao Li; Shunli Han
Journal:  J Healthc Eng       Date:  2022-04-09       Impact factor: 3.822

6.  Single Nucleotide Polymorphisms in TLR4 Affect Susceptibility to Tuberculosis in Mexican Population from the State of Veracruz.

Authors:  Enrique Ortega; Sujhey Hernández-Bazán; Beatriz Sánchez-Hernández; Ileana Licona-Limón; Javier Fuentes-Dominguez
Journal:  J Immunol Res       Date:  2020-01-29       Impact factor: 4.818

7.  IDUA Gene Variants and Response to Zoledronic Acid Treatment in Chinese Women with Postmenopausal Osteoporosis.

Authors:  Haiqing Lin; Jin Li; Zhonghua Xu; Ting Liu; Xindie Zhou
Journal:  Pharmgenomics Pers Med       Date:  2021-07-13

Review 8.  Underwhelming or Misunderstood? Genetic Variability of Pattern Recognition Receptors in Immune Responses and Resistance to Mycobacterium tuberculosis.

Authors:  Jean-Yves Dubé; Vinicius M Fava; Erwin Schurr; Marcel A Behr
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.